Asthma management during pregnancy.

Asthma is estimated to affect up to 7% of pregnancies. Patients should be aggressively managed as poor asthma control during pregnancy can lead to poor outcomes for mother and child. Though there are no randomized double-blind placebo-controlled studies of asthma medications during pregnancy, data suggests that undertreatment of asthma poses more risk to mother and fetus than does appropriate use of asthma medication. Asthma therapy includes patient education, environmental control measures, appropriate pharmacotherapy and specific allergen immunotherapy.

RCT Entities:   Population Interventions Outcomes